Search results
I’ve bought these 3 magnificent growth stocks for my ISA to build generational wealth
Fool.co.uk via Yahoo Finance UK· 3 hours agoEdward Sheldon believes these growth stocks have the potential to generate significant wealth for...
Delaying Dementia? New drug just approved
WDHN Dothan· 16 hours agoU.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early stages of the...
'Game-changing' Alzheimer's drug is approved in US - as UK decision imminent
The Sun· 2 hours ago"We are hopeful that a decision will be made later this year for Great Britain." Donanemab, made by...
New Drug Approved for Early Alzheimer’s
New York Times· 17 hours agoThe drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the...
Why it Will be 'Exceptionally Difficult' to Dethrone Novo Nordisk and Eli Lilly's Obesity Drug...
Morningstar· 5 days ago"We expect that Novo Nordisk and Eli Lilly will retain the vast majority of the market for as far as...
I’ve bought these 3 magnificent growth stocks for my ISA to build generational wealth
Motley Fool UK· 3 hours agoInvesting in growth stocks can be an excellent way to build generational wealth. Here, I’m going to...
Eli Lilly & Co (NYSE:LLY): Jim Cramer’s Best Weight Loss Stock Pick for 2024
Insider Monkey via Yahoo Finance UK· 2 days agoWe recently published a list of the 10 Stocks to Buy and Sell Before the Third Quarter 2024...
FDA approves Eli Lilly's treatment which slows symptoms down
Daily Mail· 16 hours agoThe US FDA has approved donanemab, a treatment for Alzheimer's disease that helps the body remove...
FDA Approves Second Alzheimer’s Drug after Trial Shows it Can Slow Disease by 35%
The Daily Beast via Yahoo News UK· 11 hours agoThe Federal Drug Administration gave the go-ahead to a second Alzheimer’s treatment Tuesday after a...
FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease | CNN
CNN.com· 15 hours agoThe US Food and Drug Administration on Tuesday approved donanemab, a monoclonal antibody designed to...
